Filter
2034
Text search:
mass
drug
Featured
Recommendations
195
New Publications
548
Language
Document type
No document type
1120
Studies & Reports
364
Guidelines
264
Manuals
112
Strategic & Response Plan
99
Fact sheets
28
Training Material
27
Situation Updates
8
Infographics
6
Resource Platforms
3
Online Courses
2
Brochures
1
Countries / Regions
India
139
Global
98
Kenya
63
Ethiopia
60
Uganda
58
Tanzania
45
South Africa
43
Nigeria
40
Liberia
39
Nepal
38
Bangladesh
38
Western and Central Europe
38
Sierra Leone
37
Zambia
37
Malawi
35
Rwanda
33
Ghana
31
Myanmar / Burma
29
Philippines
26
Latin America and the Carribbean
26
Namibia
24
Africa
24
Ukraine
21
Cambodia
20
Eastern Europe
19
Zimbabwe
16
South–East Asia Region
16
Asia
13
Senegal
12
Indonesia
12
Mozambique
12
Syria
11
Lesotho
11
Congo, Democratic Republic of
10
Russia
10
Eswatini/ Swaziland
9
Botswana
9
West and Central Africa
9
Brazil
7
East and Southern Africa
7
Pakistan
6
South Sudan
6
Thailand
6
Vietnam
6
Guinea
5
Haiti
5
Germany
5
Eastern Europe and Central Asia
5
Laos
5
Burkina Faso
4
USA
4
Afghanistan
4
China
4
Sudan
4
Peru
4
Middle East and North Africa
4
Western Pacific Region
4
Timor Leste/ East Timor
4
Cameroon
3
Somalia
3
Iraq
3
Turkey
3
Colombia
3
El Salvador
3
Sri Lanka
3
Yemen
3
Bhutan
3
Venezuela
3
Iran
3
Georgia
3
North America
3
United Kingdom
3
Mali
2
Saudi Arabia
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Argentina
2
Bolivia
2
Libya
2
Madagascar
2
Mexico
2
Albania
2
Tajikistan
2
Morocco
1
Egypt
1
Chad
1
Gambia
1
North Macedonia
1
Switzerland
1
Honduras
1
Ecuador
1
Greece
1
Angola
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Armenia
1
Mongolia
1
Southern Africa
1
Canada
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
890
Clinical Guidelines
185
Public Health
129
Key Resources
73
Women & Child Health
61
Capacity Building
24
Pharmacy & Technologies
17
Annual Report MEDBOX
1
Toolboxes
NTDs
179
TB
144
HIV
129
Mental Health
118
COVID-19
92
AMR
71
NCDs
69
Malaria
61
Pharmacy
47
Planetary Health
40
Rapid Response
35
Caregiver
35
Conflict
33
Refugee
31
Ebola & Marburg
27
Global Health Education
26
Cholera
15
Natural Hazards
12
Specific Hazards
12
2.0 Rapid Response
12
Health Financing Toolbox
11
Disability
9
Social Ethics
7
Zika
5
Polio
4
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of
...
Monitoramento efetivo, avaliação epidemiológica e análise subsequente são
necessários para atingir o objetivo de interromper a transmissão da FL. Este manual foi
elaborado para oferecer aos programas nacionais de eliminação da fi lariose informação de qualidade sobre metodologias e proc
...
The South-East Asia regional programme to eliminate lymphatic filariasis (LF) was launched in 2000. This study presents the progress and impact of the programme in the region.
A community-based approach.
These guidelines focus on manmade rather than natural disasters, but our experiences in India, El Salvador and Pakistan (earthquake interventions), and following the 2004 tsunami, cyclone Nargis in 2008 and the Haiti earthquake in 2010, showed that the principles describ
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o
...
Lancet Infect Dis 2020 Published Online May 5, 2020 https://doi.org/10.1016/ S1473-3099(20)30254-1
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as
...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3:
...
13280–13285 / PNAS / September 9, 2008 / vol. 105 / no. 36
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use
...
Strategic Overview
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl
...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school
...
Revised Edition
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of
...
The Sustainable Development Goals (SDGs) were launched in September 2015, made up of 17 Goals and 169 Targets that set out a plan of action that will shape the mainstream development agenda for the next 15 years1. There has already been much debate about how these Goals will be achieved, but the sig
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
